BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayyar VS, DuBois DC, Almon RR, Jusko WJ. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part III: Estrous Cycle and Estrogen Receptor-Dependent Antagonism of Glucocorticoid-Induced Leucine Zipper (GILZ) Enhancement by Corticosteroids. J Pharmacol Exp Ther 2019;370:337-49. [PMID: 31197018 DOI: 10.1124/jpet.119.257543] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Sævik ÅB, Wolff AB, Björnsdottir S, Simunkova K, Hynne MS, Dolan DWP, Bratland E, Knappskog PM, Methlie P, Carlsen S, Isaksson M, Bensing S, Kämpe O, Husebye ES, Løvås K, Øksnes M. Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison's Disease. J Endocr Soc 2021;5:bvaa202. [PMID: 33553982 DOI: 10.1210/jendso/bvaa202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ayyar VS, Song D, DuBois DC, Almon RR, Jusko WJ. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat. J Pharmacol Exp Ther 2019;370:318-26. [PMID: 31197020 DOI: 10.1124/jpet.119.257519] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
3 Ayyar VS, DuBois DC, Nakamura T, Almon RR, Jusko WJ. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression. J Pharmacol Exp Ther 2019;370:327-36. [PMID: 31197019 DOI: 10.1124/jpet.119.257527] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
4 Ayyar VS, Jusko WJ. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids. Pharmacol Rev 2020;72:414-38. [PMID: 32123034 DOI: 10.1124/pr.119.018101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
5 Mozaffari MS. Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19. J Pharmacol Exp Ther 2020;375:398-405. [PMID: 33008869 DOI: 10.1124/jpet.120.000243] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ayyar VS, Sukumaran S. Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions. J Pharmacokinet Pharmacodyn 2021;48:321-38. [PMID: 33797011 DOI: 10.1007/s10928-021-09751-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yu R, Li X, Dubois DC, Almon RR, Cao Y, Jusko WJ. Interactions of Tofacitinib and Dexamethasone on Lymphocyte Proliferation. Pharm Res 2020;37. [DOI: 10.1007/s11095-020-02827-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Laulhé M, Dumeige L, Vu TA, Hani I, Pussard E, Lombès M, Viengchareun S, Martinerie L. Sexual Dimorphism of Corticosteroid Signaling during Kidney Development. Int J Mol Sci 2021;22:5275. [PMID: 34069759 DOI: 10.3390/ijms22105275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu H, Liu L, Han H, Liu K, Wang H. Panel of suitable reference genes and its gender differences of fetal rat liver under physiological conditions and exposure to dexamethasone during pregnancy. Reprod Toxicol 2021;100:74-82. [PMID: 33453333 DOI: 10.1016/j.reprotox.2021.01.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]